HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sreerama Shetty Selected Research

caveolin-1 (82-101)

3/2022Caveolin-1-Derived Peptide Reduces ER Stress and Enhances Gelatinolytic Activity in IPF Fibroblasts.
1/2022Caveolin-1 scaffolding domain peptide abrogates autophagy dysregulation in pulmonary fibrosis.
10/2020Caveolin-1 scaffolding domain peptide regulates glucose metabolism in lung fibrosis.
12/2019Caveolin-1-derived peptide limits development of pulmonary fibrosis.
3/2016p53- and PAI-1-mediated induction of C-X-C chemokines and CXCR2: importance in pulmonary inflammation due to cigarette smoke exposure.
3/2015Role of p53-fibrinolytic system cross-talk in the regulation of quartz-induced lung injury.
1/2015Plasminogen activator inhibitor-1 in cigarette smoke exposure and influenza A virus infection-induced lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sreerama Shetty Research Topics

Disease

15Lung Injury
12/2019 - 05/2003
9Pulmonary Fibrosis (Fibrosing Alveolitis)
03/2022 - 12/2008
9Pneumonia (Pneumonitis)
01/2019 - 08/2002
6Acute Lung Injury
01/2019 - 12/2008
6Neoplasms (Cancer)
09/2010 - 08/2002
5Endotoxemia
01/2016 - 06/2003
5Carcinoma (Carcinomatosis)
09/2008 - 07/2004
4Inflammation (Inflammations)
01/2015 - 09/2010
3Fibrosis (Cirrhosis)
10/2020 - 07/2013
3Infections
07/2017 - 02/2009
3Chronic Obstructive Pulmonary Disease (COPD)
03/2016 - 01/2015
2Idiopathic Pulmonary Fibrosis
02/2018 - 01/2015
2Pleural Effusion (Pleural Effusions)
07/2017 - 08/2016
2Sepsis (Septicemia)
05/2017 - 04/2015
2Pulmonary Edema
01/2016 - 06/2003
2Acute Kidney Injury (Acute Renal Failure)
06/2014 - 01/2014
1Cytokine Release Syndrome
01/2022
1Hypoxia (Hypoxemia)
10/2020
1Empyema
07/2017
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2016
1Philadelphia Chromosome
08/2016
1Edema (Dropsy)
08/2016
1Leukemia
08/2016
1Respiratory Tract Infections (Respiratory Tract Infection)
03/2016
1Lung Diseases (Lung Disease)
04/2015
1Silicosis
03/2015
1Herpes Zoster
01/2015
1Septic Shock (Toxic Shock Syndrome)
06/2014
1Mesothelioma
09/2010
1Malignant Mesothelioma
09/2010
1Pathologic Processes
10/2006

Drug/Important Bio-Agent (IBA)

12Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
05/2017 - 05/2003
11Plasminogen Activator Inhibitor 1IBA
03/2016 - 05/2003
9Messenger RNA (mRNA)IBA
03/2016 - 01/2004
7caveolin-1 (82-101)IBA
03/2022 - 01/2015
5CytokinesIBA
01/2022 - 06/2003
5Bleomycin (Blenoxane)FDA LinkGeneric
10/2020 - 07/2013
5SmokeIBA
05/2017 - 08/2011
5EndotoxinsIBA
01/2016 - 02/2009
5Proteins (Proteins, Gene)FDA Link
03/2011 - 07/2004
5Urokinase Plasminogen Activator ReceptorsIBA
02/2010 - 05/2003
4Plasminogen Activators (Plasminogen Activator)IBA
03/2016 - 07/2008
3InflammasomesIBA
01/2019 - 04/2015
3Sirtuin 1IBA
05/2017 - 01/2014
3Carrier Proteins (Binding Protein)IBA
07/2008 - 01/2004
2EnzymesIBA
10/2020 - 03/2015
2Peptides (Polypeptides)IBA
12/2019 - 02/2018
2Silicon Dioxide (Silica)FDA LinkGeneric
05/2017 - 03/2015
2Tumor Suppressor Protein p53IBA
05/2017 - 03/2016
2CollagenIBA
04/2015 - 01/2015
2FibrinIBA
03/2012 - 06/2010
2Tyrosine (L-Tyrosine)FDA Link
03/2011 - 01/2004
1Glucose (Dextrose)FDA LinkGeneric
10/2020
1Lactic Acid (Lactate)FDA LinkGeneric
10/2020
1Succinic Acid (Succinate)IBA
10/2020
1Amino AcidsFDA Link
12/2019
1indium-bleomycinIBA
12/2019
1CAY10603IBA
01/2019
1Interleukin-6 (Interleukin 6)IBA
01/2019
1Caveolin 1IBA
02/2018
1Pulmonary Surfactant-Associated Protein CIBA
01/2017
1Protein CIBA
01/2017
1Surface-Active Agents (Surfactants)IBA
01/2017
1amsonic acid (DAS)IBA
08/2016
1Tyrosine Kinase InhibitorsIBA
08/2016
1AlbuminsIBA
08/2016
1Dasatinib (BMS 354825)FDA Link
08/2016
1CXC ChemokinesIBA
03/2016
1Interleukin-8B ReceptorsIBA
03/2016
1tubastatin AIBA
01/2016
1TubulinIBA
01/2016
1CateninsIBA
01/2016
1Phosphotransferases (Kinase)IBA
12/2015
1src-Family KinasesIBA
12/2015
1Histone Deacetylases (Histone Deacetylase)IBA
04/2015
1ChemokinesIBA
03/2015
1QuartzIBA
03/2015
1AntigensIBA
01/2015
1Plasminogen InactivatorsIBA
01/2015
1Cadherins (E-Cadherin)IBA
01/2015
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2015
1resolvin D1IBA
06/2014
13' Untranslated Regions (3' UTR)IBA
07/2013
1SerpinsIBA
08/2011
13-nitrotyrosineIBA
03/2011
1Oxidants (Oxidizing Agents)IBA
03/2011
1monoamine-sulfating phenol sulfotransferaseIBA
03/2011
1Biomarkers (Surrogate Marker)IBA
03/2011
1LipopolysaccharidesIBA
02/2009
1Serine Proteases (Serine Protease)IBA
10/2006
1Interleukin-1beta (Interleukin 1 beta)IBA
06/2003
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2003
1PlasminogenIBA
05/2003
1FibrinolysinFDA Link
05/2003
1Peptide Hydrolases (Proteases)FDA Link
08/2002

Therapy/Procedure

1Therapeutics
07/2017
1Thrombolytic Therapy
07/2017
1Punctures
04/2015
1Ligation
04/2015